- Trials with a EudraCT protocol (11,926)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11,926 result(s) found for: II.
Displaying page 98 of 597.
| EudraCT Number: 2004-002908-15 | Sponsor Protocol Number: B9E-XM-O401 | Start Date*: 2004-12-15 |
| Sponsor Name:Carlos Gómez Martín | ||
| Full Title: ENSAYO FASE I/II, MULTICENTRICO DE LA COMBINACIÓN DE CARBOPLATINO Y GEMCITABINA EN EL TRATAMIENTO DE PACIENTES CON CARCINOMA DE OVARIO EN 1ª RECIDIVA TRAS QUIMIOTERAPIA SENSIBLES A PLATINO | ||
| Medical condition: Carcinoma de ovario en primera recidiva tras quimioterapia sensible a platino | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004686-15 | Sponsor Protocol Number: LUD 03-007 | Start Date*: 2005-08-04 |
| Sponsor Name:Ludwig Institute For Cancer Research | ||
| Full Title: Phase I/II study of immunization with multiple peptides mixed with the immunological adjuvant CpG 7909 in HLA-A2 patients with metastatic melanoma ... | ||
| Medical condition: HLA-A2 patients with metastatic melanoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-001378-29 | Sponsor Protocol Number: RAE02 | Start Date*: 2005-05-23 |
| Sponsor Name:Bradford Teaching Hospitals NHS Foundation Trust | ||
| Full Title: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia. | ||
| Medical condition: Obstructed defeacation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001171-36 | Sponsor Protocol Number: TG-MV-001 | Start Date*: 2005-05-13 |
| Sponsor Name:ThromboGenics Ltd. | ||
| Full Title: A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy | ||
| Medical condition: Vitreomacular Traction Maculopathy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002081-19 | Sponsor Protocol Number: 252313 | Start Date*: 2006-10-16 |
| Sponsor Name:VU University Medical Centre | ||
| Full Title: The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis A phase II open-label safety and efficacy study. | ||
| Medical condition: Pulmonary arterial hypertension associated with systemic sclerosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002389-21 | Sponsor Protocol Number: NWCOG-3 | Start Date*: 2006-09-04 | |||||||||||
| Sponsor Name:North Wales NHS Trust | |||||||||||||
| Full Title: A phase I/II study of Docetaxel (Taxotere, TM), Cisplatinum and Capecitabine (Xeloda, TM) (TCX) in patients with advanced oesophago-gastric cancer. | |||||||||||||
| Medical condition: Locally advanced or metastatic adenocarcinoma, squamous cell carcinoma or undifferentiated carcinoma of the oesophagus, oesophago-gastric junction or stomach. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-002895-32 | Sponsor Protocol Number: ML21308 | Start Date*: 2007-08-29 |
| Sponsor Name:Roche AB | ||
| Full Title: A phase II trial assessing Metronidazol Actavis 1% topical cream in the prevention and treatment of Erlotinib associated rash | ||
| Medical condition: Erlotinib associated rash | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004566-16 | Sponsor Protocol Number: CSPP100A2238 | Start Date*: 2007-03-12 |
| Sponsor Name:Novartis Pharma Services AG | ||
| Full Title: Part 1: An open Label Pilot Study to Determine Interstitial and Tissue Concentrations of Aliskiren and Effects on the Renin-Angiotensin System (RAS) in Fat and Skeletal Muscle of Hypertensive Patie... | ||
| Medical condition: Hypertension | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-022169-91 | Sponsor Protocol Number: ONC-2010-002 | Start Date*: 2011-06-30 | ||||||||||||||||
| Sponsor Name:ISTITUTO CLINICO HUMANITAS | ||||||||||||||||||
| Full Title: PHASE II STUDY WITH BENDAMUSTINE GEMCITABINE AND VINORELBINE (BeGEV) AS INDUCTION THERAPY IN RELAPSED/REFRACTORY HODGKIN’S LYMPHOMA PATIENTS BEFORE HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIE... | ||||||||||||||||||
| Medical condition: patients with relapsed-refractory Hodgkin's Lymphoma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: IT (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2008-002152-26 | Sponsor Protocol Number: ISRCTN86894066 | Start Date*: 2009-01-20 | |||||||||||
| Sponsor Name:The Royal Marsden Foundation Trust and The Institute of Cancer Research | |||||||||||||
| Full Title: Randomised double-blind controlled phase III trial of hyperbaric oxygen therapy in patients suffering long-term adverse effects of radiotherapy for pelvic cancer | |||||||||||||
| Medical condition: Chronic radiation-induced gastrointestinal symptoms | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-004511-39 | Sponsor Protocol Number: DCC04AM005 | Start Date*: 2005-04-29 |
| Sponsor Name:Dr. Theiss Naturwaren GmbH | ||
| Full Title: Double blind (observer Blind) Placebo controlled, clinical-experimental Study of the Phase II for the examination of the local tolerance by Duhring-Chamber-Test as well as open user trial of the pr... | ||
| Medical condition: healthy subjects with normal skin conditions | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000482-35 | Sponsor Protocol Number: ARA102198 | Start Date*: 2004-10-11 |
| Sponsor Name:GlaxoSmithKline Research & Development Ltd. | ||
| Full Title: A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arth... | ||
| Medical condition: Rheumatoid Arthritis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) LT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004632-40 | Sponsor Protocol Number: AGO 2005/ANE/propsev | Start Date*: 2005-11-25 |
| Sponsor Name:University Hospital Ghent | ||
| Full Title: Study on the pharmacodynamic interactions between propofol and sevoflurane during induction of anesthesia. | ||
| Medical condition: Anesthesia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-002180-90 | Sponsor Protocol Number: Hypergliom2005 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Neurologische Uniklinik Regensburg | ||
| Full Title: Lókoregionale Tiefenhyperthermie begleitend zu ACNU in der Rezidivtherapie von Patienten mit malignen Gliomen (WHO°III/IV)- Phase I/II-Studie | ||
| Medical condition: Recurrent malignant glioma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-004282-34 | Sponsor Protocol Number: 2833 | Start Date*: 2006-10-13 |
| Sponsor Name:Royal Marsden NHS Foundation Trust | ||
| Full Title: A phase II study of bethanechol chloride to treat pseudomembranous candidosis in cancer patients with salivary gland dysfunction. | ||
| Medical condition: Oral candidosis (pseudomembranous subtype) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-006174-97 | Sponsor Protocol Number: BST22006 | Start Date*: 2007-05-02 |
| Sponsor Name:University of Oxford, Research Governance & Clinical Trials Office | ||
| Full Title: Which oxygen saturation level should we use for very premature infants? A randomised controlled trial (BOOST-II UK) | ||
| Medical condition: Respiratory distress of newborn ICD codes P22.0, P22.8, P22.9 | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) IE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-007042-35 | Sponsor Protocol Number: 2005/07 | Start Date*: 2008-04-04 | |||||||||||
| Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
| Full Title: Phase II trial of transdermic buprenorfine in children with pain cancer | |||||||||||||
| Medical condition: pain cancer in children | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-010736-18 | Sponsor Protocol Number: C1 1207 | Start Date*: 2009-05-04 |
| Sponsor Name:Pharming Technologies B.V. | ||
| Full Title: An open-label exploratory Phase II study of the safety and prophylactic effect of a weekly 50 U/kg rC1INH treatment in asymptomatic patients with hereditary C1INH deficiency (HAE) | ||
| Medical condition: Explore the effect of rC1INH in patients with HAE in preventing the occurence of acute HAE attacks. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-004155-39 | Sponsor Protocol Number: BAY1000394/14858 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Bayer Healthcare AG | |||||||||||||
| Full Title: Phase Ib / II study of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide as first-line therapy in subjects with extensive disease small cell lung cancer | |||||||||||||
| Medical condition: Subjects with histologically or cytologically confirmed, extensive disease SCLC without prior systemic antitumor therapy are eligible. Subjects should have evaluable or measurable disease. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-002516-33 | Sponsor Protocol Number: NCT01420393 | Start Date*: 2015-09-03 |
| Sponsor Name:University of Ottawa Heart Institute | ||
| Full Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus rate control Trial in patients with heart failure and high burden Atrial Fibrillation | ||
| Medical condition: The study is comparing two accepted treatment methods (rhythm control-Catheter ablation with or without anti-arrhythmic drug control of maintaining sinus rhythm versus rate controls with medical th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
